Colinz Laboratories Limited (BOM:531210)
India · Delayed Price · Currency is INR 44.01
-1.29 (-2.85%)
At close: Mar 5, 2026
Colinz Laboratories Market Cap
Colinz Laboratories has a market cap or net worth of 105.42 million as of March 6, 2026. Its market cap has decreased by -19.21% in one year.
Market Cap
105.42M
Enterprise Value
37.82M
Revenue
58.40M
Ranking
n/a
PE Ratio
21.35
Stock Price
44.01
Market Cap Chart
Since May 26, 2005, Colinz Laboratories's market cap has increased from 39.08M to 105.42M, an increase of 169.75%. That is a compound annual growth rate of 4.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 105.42M | -21.97% |
| Dec 31, 2025 | 135.10M | -23.12% |
| Dec 31, 2024 | 175.73M | 74.40% |
| Dec 29, 2023 | 100.76M | -48.73% |
| Dec 30, 2022 | 196.55M | 55.52% |
| Dec 31, 2021 | 126.39M | 93.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hamps Bio | 152.46M |
| Ortin Global | 140.19M |
| Desh Rakshak Aushdhalaya | 131.97M |
| Norris Medicines | 130.01M |
| Cian Healthcare | 125.23M |
| Emmessar Biotech & Nutrition | 123.90M |
| Shamrock Industrial Company | 110.51M |
| Beryl Drugs | 101.23M |